Clarithromycin and simvastatin — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Clarithromycin can increase simvastatin exposure and myopathy risk.
Clarithromycin strongly inhibits CYP3A4 and can markedly increase simvastatin concentrations, increasing myopathy and rhabdomyolysis risk. The prescriber should be contacted to withhold simvastatin or choose an alternative antibiotic where appropriate. Amlodipine interactions may also matter, but simvastatin is the key high-risk issue here.
Reference: BNF